American Century Companies’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-47,406
Closed -$529K 2980
2025
Q1
$529K Buy
47,406
+7,694
+19% +$85K ﹤0.01% 2490
2024
Q4
$409K Buy
39,712
+121
+0.3% +$1.17K ﹤0.01% 2568
2024
Q3
$376K Buy
39,591
+3,694
+10% +$31.9K ﹤0.01% 2568
2024
Q2
$306K Buy
35,897
+5,253
+17% +$48.1K ﹤0.01% 2619
2024
Q1
$283K Buy
30,644
+7,038
+30% +$61.9K ﹤0.01% 2664
2023
Q4
$229K Buy
+23,606
New +$221K ﹤0.01% 2652
2022
Q2
Sell
-393,183
Closed -$5M 2394
2022
Q1
$5M Sell
393,183
-148,546
-27% -$2.27M ﹤0.01% 1114
2021
Q4
$11.3M Buy
+541,729
New +$10.9M 0.01% 844

Other funds holding ENFN

American Century Companies's ENFN Position: Q2 2025 in Review

American Century Companies sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 47,406 shares — an estimated $529K sold.

American Century Companies first reported a position in ENFN in Q4 2021 and held it in 8 quarters. The position peaked at $11.3M in Q4 2021. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • American Century Companies reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • American Century Companies sold 47,406 Enfusion, Inc. shares in Q2 2025, an estimated $529K.
  • American Century Companies first reported a position in Enfusion, Inc. in Q4 2021 and held it in 8 quarters.
  • American Century Companies's Enfusion, Inc. position peaked at $11.3M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on American Century Companies's 13F filing for Q2 2025, filed 12 Aug 2025.